Quantitative Multiplex Immunofluorescence evaluation of the tumor microenvironment in pretreatment tumors of patients with metastatic breast cancer and serous ovarian carcinoma treated with liposomal eribulin.

Douglas K. Marks,John Kucharczyk,Pan Kim,Donian Chyong,Robyn D. Gartrell,Yan Lu,Hanina Hibshoosh,Hua Guo,T. R. J. Evans,Juanita Lopez,Rebecca Kristeleit,Eileen P. Connolly,Yvonne M. Saenger,Kevin Kalinsky

Quantitative Multiplex Immunofluorescence evaluation of the tumor microenvironment in pretreatment tumors of patients with metastatic breast cancer and serous ovarian carcinoma treated with liposomal eribulin.

2021

Douglas K. Marks
John Kucharczyk
Pan Kim
Donian Chyong
Robyn D. Gartrell
Yan Lu
Hanina Hibshoosh
Hua Guo
T. R. J. Evans
Juanita Lopez
Rebecca Kristeleit
Eileen P. Connolly
Yvonne M. Saenger
Kevin Kalinsky

Eribulin inhibits microtubule polymerization and suppresses epithelial-mesenchymal transition. Conventional pathology approaches have not identified a precise predictive biomarker for Eribulin. We ...

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations